Asthma and regular beta agonist therapy. 1991

J Crane

UI MeSH Term Description Entries
D005280 Fenoterol A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. Berotec,Berotek,Fenoterol Hydrobromide,Fenoterol Hydrochloride,Partusisten,Phenoterol,Th-1165a,p-Hydroxyphenyl-orciprenaline,p-Hydroxyphenylorciprenaline,Hydrochloride, Fenoterol,Th 1165a,Th1165a,p Hydroxyphenyl orciprenaline,p Hydroxyphenylorciprenaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

J Crane
September 1991, BMJ (Clinical research ed.),
J Crane
December 1990, Lancet (London, England),
J Crane
June 1992, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
J Crane
August 1992, Australian and New Zealand journal of medicine,
J Crane
September 1993, The American review of respiratory disease,
J Crane
July 1992, The European respiratory journal,
J Crane
September 2001, American journal of respiratory and critical care medicine,
J Crane
February 1990, The European respiratory journal,
Copied contents to your clipboard!